Interleukin 21 (IL21) (C-Term) Peptide
IL21
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all IL-21 (IL21) products
- IL-21 (IL21) (Interleukin 21 (IL21))
- Protein Region
- C-Term
- Origin
- Human
- Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- ERIINVSIKK LKRKPPSTNA GRRQKHRLTC PSCDSYEKKP PKEFLERFKS
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-IL21 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeat freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IL-21 (IL21) (Interleukin 21 (IL21))
- Synonyms
- IL-21 Peptide, Za11 Peptide, interleukin 21 Peptide, IL21 Peptide, Il21 Peptide
- Background
-
This gene encodes a member of the common-gamma chain family of cytokines with immunoregulatory activity. The encoded protein plays a role in both the innate and adaptive immune responses by inducing the differentiation, proliferation and activity of multiple target cells including macrophages, natural killer cells, B cells and cytotoxic T cells. Dysregulation of this gene plays a role in multiple immune-mediated diseases including lupus, psoriasis and chronic inflammatory diseases. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Alias Symbols: IL-21, Za11
Protein Size: 153 - Molecular Weight
- 16 kDa
- Gene ID
- 59067
- NCBI Accession
- NM_001207006, NP_001193935
-
You are here:
